LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Inicio・Lista de Acciones・Danaher Corp
Search

Danaher Corp

Cerrado

SectorSanidad

161.94 -1.59

Compra Fuerte

Precios actualizados 15 may 2026, 19:59 UTC

ComprarVender

Resumen

Variación precio

24h

Actual

Mínimo

160.93

Máximo

165.5

Métricas clave

By Trading Economics

Ingresos

-168M

1B

Ventas

-887M

6B

P/B

Media del Sector

32.334

51.415

BPA

2.06

Rentabilidad por dividendo

0.79

Margen de beneficios

17.291

Empleados

58,000

EBITDA

-514M

1.5B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+40.03% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.79%

2.34%

Próximas Ganancias

21 jul 2026

Fecha Próximo Dividendo

31 jul 2026

Próxima Fecha de Ex Dividendo

26 jun 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-20B

118B

Apertura anterior

163.53

Cierre anterior

161.94

Noticias sobre sentimiento de mercado

By Acuity

55%

45%

280 / 345 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

189.8851 / 196.5 Soporte y Resistencia

Danaher Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

21 abr 2026, 11:36 UTC

Ganancias

Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains -- Update

DJ

Leer

21 abr 2026, 11:00 UTC

Ganancias

Danaher Raises Adjusted Earnings Guidance, 1Q Revenue, Profit Rise

DJ

Leer

21 abr 2026, 10:06 UTC

Ganancias

Danaher 1Q Adjsuted Core Revenue Rose 0.5% >DHR

DJ

Leer

21 abr 2026, 10:05 UTC

Ganancias

Danaher Sees 2Q Adjsuted Core Revenue Up Low-Single Digits >DHR

DJ

Leer

21 abr 2026, 10:05 UTC

Ganancias

Danaher Still Sees 2026 Adjsuted Core Revenue Up 3%-6% >DHR

DJ

Leer

21 abr 2026, 10:05 UTC

Ganancias

Danaher Had Seen 2026 Adjusted EPS $8.35-$8.50 >DHR

DJ

Leer

21 abr 2026, 10:04 UTC

Ganancias

Danaher Raises 2026 View To Adj EPS $8.35-Adj EPS $8.55 >DHR

DJ

Leer

21 abr 2026, 10:04 UTC

Ganancias

Danaher 1Q Operating Cash Flow $1.3B, Adjusted Free Cash Flow $1.1B >DHR

DJ

Leer

21 abr 2026, 10:00 UTC

Ganancias

Danaher 1Q Cont Ops EPS $1.45 >DHR

DJ

Leer

21 abr 2026, 10:00 UTC

Ganancias

Danaher 1Q Adj EPS $2.06 >DHR

DJ

Leer

21 abr 2026, 10:00 UTC

Ganancias

Danaher 1Q Sales $5.95B >DHR

DJ

Leer

21 abr 2026, 10:00 UTC

Ganancias

Danaher 1Q EPS $1.45 >DHR

DJ

Leer

21 abr 2026, 10:00 UTC

Ganancias

Danaher 1Q Net $1.03B >DHR

DJ

Leer

17 abr 2026, 19:15 UTC

Charlas de Mercado

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

DJ

Leer

17 abr 2026, 19:07 UTC

Charlas de Mercado

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

DJ

Leer

17 feb 2026, 20:06 UTC

Adquisiciones, fusiones, absorciones

This Medical-Devices Stock Is Soaring. Danaher Is Buying the Company. -- Barrons.com

DJ

Leer

17 feb 2026, 15:14 UTC

Adquisiciones, fusiones, absorciones

Masimo Stock on Pace for Record Gains After Danaher Strikes Deal -- WSJ

DJ

Leer

17 feb 2026, 14:39 UTC

Adquisiciones, fusiones, absorciones

This Medical-Devices Stock Is Soaring. It's Being Bought by Danaher. -- Barrons.com

DJ

Leer

17 feb 2026, 13:30 UTC

Adquisiciones, fusiones, absorciones

This Medical-Devices Stock Is Soaring. It's Being Bought by Danaher. -- Barrons.com

DJ

Leer

17 feb 2026, 13:15 UTC

Adquisiciones, fusiones, absorciones

Danaher Strikes $10 Billion Deal for Masimo -- Update

DJ

Leer

17 feb 2026, 13:03 UTC

Adquisiciones, fusiones, absorciones

Danaher To Fund Masimo Acquisition With Cash on Hand, Debt Financing >DHR

DJ

Leer

17 feb 2026, 13:03 UTC

Adquisiciones, fusiones, absorciones

Danaher Sees More Than $125M Annual Cost Synergies, More Than $50M Annual Revenue Synergies by Fifth Full Year >DHR MASI

DJ

Leer

17 feb 2026, 13:02 UTC

Adquisiciones, fusiones, absorciones

Danaher Sees Masimo Deal Adding About 70c to Adjusted EPS in Fifth Full Year >DHR MASI

DJ

Leer

17 feb 2026, 13:02 UTC

Adquisiciones, fusiones, absorciones

Danaher Sees Masimo Deal Adding 15c-20c to Adjusted EPS in First Full Year >DHR MASI

DJ

Leer

17 feb 2026, 13:02 UTC

Adquisiciones, fusiones, absorciones

Masimo To Be Acquired By Danaher For $180.00 Per Share >MASI DHR

DJ

Leer

17 feb 2026, 13:01 UTC

Adquisiciones, fusiones, absorciones

Danaher to Buy Masimo for Total Enterprise Value of About $9.9 Billion >DHR MASI

DJ

Leer

17 feb 2026, 13:00 UTC

Adquisiciones, fusiones, absorciones

Danaher to Buy Masimo for $180/Share >DHR MASI

DJ

Leer

17 feb 2026, 13:00 UTC

Adquisiciones, fusiones, absorciones

Danaher To Acquire Masimo Corporation >DHR MASI

DJ

Leer

17 feb 2026, 11:09 UTC

Adquisiciones, fusiones, absorciones

Danaher Strikes $10 Billion Deal for Masimo -- WSJ

DJ

Leer

17 feb 2026, 11:09 UTC

Adquisiciones, fusiones, absorciones

Danaher Acquisition of Masimo Set to Be Announced Tuesday, Sources Say -- WSJ

DJ

Leer

Comparación entre iguales

Cambio de precio

Danaher Corp previsión

Precio Objetivo

By TipRanks

40.03% repunte

Estimación a 12 Meses

Media 230.4 USD  40.03%

Máximo 270 USD

Mínimo 184.04 USD

De acuerdo con 16 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Danaher Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

16 ratings

14

Comprar

2

Mantener

0

Vender

De acuerdo con 16 analistas que ofrecen calificaciones bursátiles a para Danaher Corp Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

189.8851 / 196.5Soporte y Resistencia

Corto Plazo

Bullish Evidence

Recent bullish events outweigh bearish events.

Medio plazo

Weak Bullish Evidence

There is one bullish event.

Largo Plazo

Neutral Evidence

The bullish and bearish events are balanced.

Sentimiento

By Acuity

280 / 345 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura bajista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Danaher Corp

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Otras acciones del sector

LLY

Eli Lilly and Co.

1,004

↓-0.33%

JNJ

Johnson and Johnson

226.76

↓-1.74%

ABBV

AbbVie Inc

210.42

↓-0.19%

UNH

UnitedHealth Group Inc

393.66

↓-1.34%

AZN

AstraZeneca PLC

181.62

↓-1.79%